Close
Close
Treatment Database
efmitermant alfa
Trade Name not avaiable
Orphan Indication Charcot-Marie-Tooth disease
USA Market Approval
USA Designation Date 28-02-2019
Sponsor Acceleron Pharma Inc.
128 Sidney Street
Cambridge, Massachusetts, 02139
More about Charcot-Marie-Tooth disease
Free Newsletter
Related Videos